Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,438 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer.
Passiglia F, Caparica R, Giovannetti E, Giallombardo M, Listi A, Diana P, Cirrincione G, Caglevic C, Raez LE, Russo A, Rolfo C. Passiglia F, et al. Among authors: russo a. Expert Opin Investig Drugs. 2016;25(4):385-92. doi: 10.1517/13543784.2016.1152261. Epub 2016 Feb 24. Expert Opin Investig Drugs. 2016. PMID: 26881293 Review.
Anti-endothelin drugs in solid tumors.
Russo A, Bronte G, Rizzo S, Fanale D, Di Gaudio F, Gebbia N, Bazan V. Russo A, et al. Expert Opin Emerg Drugs. 2010 Mar;15(1):27-40. doi: 10.1517/14728210903571667. Expert Opin Emerg Drugs. 2010. PMID: 20102289 Free article. Review.
Monoclonal antibodies in gastrointestinal cancers.
Bronte G, Cicero G, Cusenza S, Galvano A, Musso E, Rizzo S, Sortino G, Roselli M, Bazan V, Fiorentino E, Russo A. Bronte G, et al. Among authors: russo a. Expert Opin Biol Ther. 2013 Jun;13(6):889-900. doi: 10.1517/14712598.2013.774367. Epub 2013 Feb 27. Expert Opin Biol Ther. 2013. PMID: 23441760 Free article. Review.
Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting.
Rolfo C, Russo A, Santini D, Bronte G, Peeters M. Rolfo C, et al. Among authors: russo a. Expert Opin Ther Targets. 2013 Aug;17(8):869-71. doi: 10.1517/14728222.2013.818135. Epub 2013 Jul 15. Expert Opin Ther Targets. 2013. PMID: 23848525
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects.
Bronte G, Rolfo C, Giovannetti E, Cicero G, Pauwels P, Passiglia F, Castiglia M, Rizzo S, Vullo FL, Fiorentino E, Van Meerbeeck J, Russo A. Bronte G, et al. Among authors: russo a. Crit Rev Oncol Hematol. 2014 Feb;89(2):300-13. doi: 10.1016/j.critrevonc.2013.08.003. Epub 2013 Aug 28. Crit Rev Oncol Hematol. 2014. PMID: 24041630
4,438 results